NASDAQ:FOLD

Amicus Therapeutics Stock Predictions

etoro logo Buy FOLD
*Your capital is at risk
$14.49
+0 (+0%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

FOLD Prediction Chart

FOLD Predictions History

Latest community submissions for FOLD.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 24, 2023 $14.00 +7.20% $13.39 V 95.44% 1
JS JS Pro
Mar 5, 2021 $10.53 +0.48% $10.48 X 99.52% 5
Mar 5, 2021 $10.80 +3.05% $10.48 X 96.95% 0
Feb 17, 2021 Bearish $12.14 X 0
joe1234 joe1234 Pro
May 8, 2019 $13.36 +1.91% $13.11 X 98.09% 0
May 7, 2019 $13.92 +1.84% $13.67 X 98.16% 0
May 6, 2019 $13.48 -5.17% $14.22 X 94.83% 0
May 3, 2019 $13.89 -0.71% $13.99 X 99.29% 3
Apr 29, 2019 $13.72 +2.08% $13.44 X 97.92% 0
JS JS Pro
Aug 14, 2018 $14.25 +2.37% $13.92 X 97.60% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for FOLD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AMICUS THERAPEUTICS
Amicus Therapeutics
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE